Data without borders: sharing information ‘is key’ in race to track down deadly viruses
- Major challenge in coronavirus response is to ensure that vaccines and treatments are safe and effective, researcher says
- Advances in genetics and linked international web of laboratories could be ‘the safety net of the future’
Paul Kellam, from Imperial College London, offered the assessment on Monday in an online panel discussion on the latest advances in treating Covid-19 and vaccine development.
The event, organised by the Jack Ma and Alibaba foundations and Alibaba Health, also included New York-based David Ho, a researcher known for championing treatments that have turned Aids into a largely manageable chronic disease, and Sharon Lewin from the Peter Doherty Institute in Australia.
Alibaba owns the South China Morning Post.
Kellam, a professor of virus genomics, said it had been encouraging to see the proactive sharing of virus generic sequences from many countries, and this was key to helping predict the severity among patients with Sars-CoV-2, the official name for the coronavirus that causes Covid-19.